Correlation analysis showed that except for CXCL8 and CCL2, the other six targets (MAPK8, CTNNB1, NFKB1, EGFR, BCL2, and NFE2L2) were significantly positively linked to both Aβ and tau pathology of AD. Here, BCL2 is linked to Alzheimer disease.